Current advanced molecular technologies, including bi-directional sequencing and High Resolution DNA Melting Analysis, allow researchers to retrieve a widespread number of mutations in the BRCA1/2 genes of patients with a familial history of breast cancer [103, 104]. This evidence concerns the gene BRCA1 and breast carcinoma.